 | • レポートコード：MRC2Q12-19005 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、夜尿症治療薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 夜尿症治療薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 夜尿症治療薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 夜尿症治療薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの夜尿症治療薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の夜尿症治療薬の売上および2028年までの予測に焦点を当てています。 夜尿症治療薬のグローバル主要企業には、Allergan、Ferring Pharmaceuticals, Inc.、Pfizer Inc.、Janssen Pharmaceuticals, Inc.、Urovant Sciences, Inc.、Astellas Pharma US, Inc.、Bayer Corp、Mallinckrodt, Inc.、Shanghai Xudong Haipu Pharmaceutical Co., Ltd、Guangdong Xianqiang Pharmaceutical Co., Ltd、Beijing Zizhu Pharmaceutical Co., Ltd、Shanghai Pharmaceutical Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 夜尿症治療薬市場は、タイプとアプリケーションによって区分されます。世界の夜尿症治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 抗コリン薬、三環系抗うつ薬、デスモプレシン 【アプリケーション別セグメント】 病院、専門クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 夜尿症治療薬製品概要 - タイプ別市場（抗コリン薬、三環系抗うつ薬、デスモプレシン） - アプリケーション別市場（病院、専門クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の夜尿症治療薬販売量予測2017-2028 - 世界の夜尿症治療薬売上予測2017-2028 - 夜尿症治療薬の地域別販売量 - 夜尿症治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別夜尿症治療薬販売量 - 主要メーカー別夜尿症治療薬売上 - 主要メーカー別夜尿症治療薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（抗コリン薬、三環系抗うつ薬、デスモプレシン） - 夜尿症治療薬のタイプ別販売量 - 夜尿症治療薬のタイプ別売上 - 夜尿症治療薬のタイプ別価格 ・アプリケーション別市場規模（病院、専門クリニック、その他） - 夜尿症治療薬のアプリケーション別販売量 - 夜尿症治療薬のアプリケーション別売上 - 夜尿症治療薬のアプリケーション別価格 ・北米市場 - 北米の夜尿症治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の夜尿症治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの夜尿症治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の夜尿症治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の夜尿症治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の夜尿症治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の夜尿症治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の夜尿症治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの夜尿症治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の夜尿症治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Allergan、Ferring Pharmaceuticals, Inc.、Pfizer Inc.、Janssen Pharmaceuticals, Inc.、Urovant Sciences, Inc.、Astellas Pharma US, Inc.、Bayer Corp、Mallinckrodt, Inc.、Shanghai Xudong Haipu Pharmaceutical Co., Ltd、Guangdong Xianqiang Pharmaceutical Co., Ltd、Beijing Zizhu Pharmaceutical Co., Ltd、Shanghai Pharmaceutical Group ・産業チェーン及び販売チャネル分析 - 夜尿症治療薬の産業チェーン分析 - 夜尿症治療薬の原材料 - 夜尿症治療薬の生産プロセス - 夜尿症治療薬の販売及びマーケティング - 夜尿症治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 夜尿症治療薬の産業動向 - 夜尿症治療薬のマーケットドライバー - 夜尿症治療薬の課題 - 夜尿症治療薬の阻害要因 ・主な調査結果 |
The drugs used to treat enuresis are mainly stimulants of central nervous system or antidiuretic hormones
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Drugs for Enuresis is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Drugs for Enuresis is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Drugs for Enuresis is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Drugs for Enuresis include Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc. and Shanghai Xudong Haipu Pharmaceutical Co., Ltd, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Drugs for Enuresis manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Drugs for Enuresis market. Further, it explains the major drivers and regional dynamics of the global Drugs for Enuresis market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Allergan
Ferring Pharmaceuticals, Inc.
Pfizer Inc.
Janssen Pharmaceuticals, Inc.
Urovant Sciences, Inc.
Astellas Pharma US, Inc.
Bayer Corp
Mallinckrodt, Inc.
Shanghai Xudong Haipu Pharmaceutical Co., Ltd
Guangdong Xianqiang Pharmaceutical Co., Ltd
Beijing Zizhu Pharmaceutical Co., Ltd
Shanghai Pharmaceutical Group
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Drugs for Enuresis Segment by Type
Anticholinergic Drugs
Tricyclic Antidepressants
Desmopressin
Drugs for Enuresis Segment by Application
Hospital
Specialist Clinic
Othere
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drugs for Enuresis market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Drugs for Enuresis, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Drugs for Enuresis, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Drugs for Enuresis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs for Enuresis sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Drugs for Enuresis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Drugs for Enuresis sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc. and Shanghai Xudong Haipu Pharmaceutical Co., Ltd, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Drugs for Enuresis in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Drugs for Enuresis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Enuresis sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Drugs for Enuresis Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Enuresis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anticholinergic Drugs
1.2.3 Tricyclic Antidepressants
1.2.4 Desmopressin
1.3 Market by Application
1.3.1 Global Drugs for Enuresis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Othere
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drugs for Enuresis Sales Estimates and Forecasts 2017-2028
2.2 Global Drugs for Enuresis Revenue Estimates and Forecasts 2017-2028
2.3 Global Drugs for Enuresis Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drugs for Enuresis Sales by Region
2.4.1 Global Drugs for Enuresis Sales by Region (2017-2022)
2.4.2 Global Sales Drugs for Enuresis by Region (2023-2028)
2.5 Global Drugs for Enuresis Revenue by Region
2.5.1 Global Drugs for Enuresis Revenue by Region (2017-2022)
2.5.2 Global Drugs for Enuresis Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drugs for Enuresis Sales by Manufacturers
3.1.1 Global Top Drugs for Enuresis Manufacturers by Sales (2017-2022)
3.1.2 Global Drugs for Enuresis Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drugs for Enuresis in 2021
3.2 Global Drugs for Enuresis Revenue by Manufacturers
3.2.1 Global Drugs for Enuresis Revenue by Manufacturers (2017-2022)
3.2.2 Global Drugs for Enuresis Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drugs for Enuresis Revenue in 2021
3.3 Global Drugs for Enuresis Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drugs for Enuresis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drugs for Enuresis Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drugs for Enuresis Sales by Type
4.1.1 Global Drugs for Enuresis Historical Sales by Type (2017-2022)
4.1.2 Global Drugs for Enuresis Forecasted Sales by Type (2023-2028)
4.1.3 Global Drugs for Enuresis Sales Market Share by Type (2017-2028)
4.2 Global Drugs for Enuresis Revenue by Type
4.2.1 Global Drugs for Enuresis Historical Revenue by Type (2017-2022)
4.2.2 Global Drugs for Enuresis Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drugs for Enuresis Revenue Market Share by Type (2017-2028)
4.3 Global Drugs for Enuresis Price by Type
4.3.1 Global Drugs for Enuresis Price by Type (2017-2022)
4.3.2 Global Drugs for Enuresis Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drugs for Enuresis Sales by Application
5.1.1 Global Drugs for Enuresis Historical Sales by Application (2017-2022)
5.1.2 Global Drugs for Enuresis Forecasted Sales by Application (2023-2028)
5.1.3 Global Drugs for Enuresis Sales Market Share by Application (2017-2028)
5.2 Global Drugs for Enuresis Revenue by Application
5.2.1 Global Drugs for Enuresis Historical Revenue by Application (2017-2022)
5.2.2 Global Drugs for Enuresis Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drugs for Enuresis Revenue Market Share by Application (2017-2028)
5.3 Global Drugs for Enuresis Price by Application
5.3.1 Global Drugs for Enuresis Price by Application (2017-2022)
5.3.2 Global Drugs for Enuresis Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drugs for Enuresis Market Size by Type
6.1.1 North America Drugs for Enuresis Sales by Type (2017-2028)
6.1.2 North America Drugs for Enuresis Revenue by Type (2017-2028)
6.2 North America Drugs for Enuresis Market Size by Application
6.2.1 North America Drugs for Enuresis Sales by Application (2017-2028)
6.2.2 North America Drugs for Enuresis Revenue by Application (2017-2028)
6.3 North America Drugs for Enuresis Market Size by Country
6.3.1 North America Drugs for Enuresis Sales by Country (2017-2028)
6.3.2 North America Drugs for Enuresis Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Drugs for Enuresis Market Size by Type
7.1.1 Europe Drugs for Enuresis Sales by Type (2017-2028)
7.1.2 Europe Drugs for Enuresis Revenue by Type (2017-2028)
7.2 Europe Drugs for Enuresis Market Size by Application
7.2.1 Europe Drugs for Enuresis Sales by Application (2017-2028)
7.2.2 Europe Drugs for Enuresis Revenue by Application (2017-2028)
7.3 Europe Drugs for Enuresis Market Size by Country
7.3.1 Europe Drugs for Enuresis Sales by Country (2017-2028)
7.3.2 Europe Drugs for Enuresis Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drugs for Enuresis Market Size by Type
8.1.1 Asia Pacific Drugs for Enuresis Sales by Type (2017-2028)
8.1.2 Asia Pacific Drugs for Enuresis Revenue by Type (2017-2028)
8.2 Asia Pacific Drugs for Enuresis Market Size by Application
8.2.1 Asia Pacific Drugs for Enuresis Sales by Application (2017-2028)
8.2.2 Asia Pacific Drugs for Enuresis Revenue by Application (2017-2028)
8.3 Asia Pacific Drugs for Enuresis Market Size by Region
8.3.1 Asia Pacific Drugs for Enuresis Sales by Region (2017-2028)
8.3.2 Asia Pacific Drugs for Enuresis Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drugs for Enuresis Market Size by Type
9.1.1 Latin America Drugs for Enuresis Sales by Type (2017-2028)
9.1.2 Latin America Drugs for Enuresis Revenue by Type (2017-2028)
9.2 Latin America Drugs for Enuresis Market Size by Application
9.2.1 Latin America Drugs for Enuresis Sales by Application (2017-2028)
9.2.2 Latin America Drugs for Enuresis Revenue by Application (2017-2028)
9.3 Latin America Drugs for Enuresis Market Size by Country
9.3.1 Latin America Drugs for Enuresis Sales by Country (2017-2028)
9.3.2 Latin America Drugs for Enuresis Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Drugs for Enuresis Market Size by Type
10.1.1 Middle East and Africa Drugs for Enuresis Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drugs for Enuresis Revenue by Type (2017-2028)
10.2 Middle East and Africa Drugs for Enuresis Market Size by Application
10.2.1 Middle East and Africa Drugs for Enuresis Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drugs for Enuresis Revenue by Application (2017-2028)
10.3 Middle East and Africa Drugs for Enuresis Market Size by Country
10.3.1 Middle East and Africa Drugs for Enuresis Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drugs for Enuresis Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Ferring Pharmaceuticals, Inc.
11.2.1 Ferring Pharmaceuticals, Inc. Corporation Information
11.2.2 Ferring Pharmaceuticals, Inc. Overview
11.2.3 Ferring Pharmaceuticals, Inc. Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ferring Pharmaceuticals, Inc. Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ferring Pharmaceuticals, Inc. Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Overview
11.3.3 Pfizer Inc. Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Inc. Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Inc. Recent Developments
11.4 Janssen Pharmaceuticals, Inc.
11.4.1 Janssen Pharmaceuticals, Inc. Corporation Information
11.4.2 Janssen Pharmaceuticals, Inc. Overview
11.4.3 Janssen Pharmaceuticals, Inc. Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Janssen Pharmaceuticals, Inc. Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Janssen Pharmaceuticals, Inc. Recent Developments
11.5 Urovant Sciences, Inc.
11.5.1 Urovant Sciences, Inc. Corporation Information
11.5.2 Urovant Sciences, Inc. Overview
11.5.3 Urovant Sciences, Inc. Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Urovant Sciences, Inc. Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Urovant Sciences, Inc. Recent Developments
11.6 Astellas Pharma US, Inc.
11.6.1 Astellas Pharma US, Inc. Corporation Information
11.6.2 Astellas Pharma US, Inc. Overview
11.6.3 Astellas Pharma US, Inc. Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Astellas Pharma US, Inc. Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Astellas Pharma US, Inc. Recent Developments
11.7 Bayer Corp
11.7.1 Bayer Corp Corporation Information
11.7.2 Bayer Corp Overview
11.7.3 Bayer Corp Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bayer Corp Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer Corp Recent Developments
11.8 Mallinckrodt, Inc.
11.8.1 Mallinckrodt, Inc. Corporation Information
11.8.2 Mallinckrodt, Inc. Overview
11.8.3 Mallinckrodt, Inc. Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mallinckrodt, Inc. Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mallinckrodt, Inc. Recent Developments
11.9 Shanghai Xudong Haipu Pharmaceutical Co., Ltd
11.9.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Corporation Information
11.9.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Overview
11.9.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Recent Developments
11.10 Guangdong Xianqiang Pharmaceutical Co., Ltd
11.10.1 Guangdong Xianqiang Pharmaceutical Co., Ltd Corporation Information
11.10.2 Guangdong Xianqiang Pharmaceutical Co., Ltd Overview
11.10.3 Guangdong Xianqiang Pharmaceutical Co., Ltd Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Guangdong Xianqiang Pharmaceutical Co., Ltd Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Guangdong Xianqiang Pharmaceutical Co., Ltd Recent Developments
11.11 Beijing Zizhu Pharmaceutical Co., Ltd
11.11.1 Beijing Zizhu Pharmaceutical Co., Ltd Corporation Information
11.11.2 Beijing Zizhu Pharmaceutical Co., Ltd Overview
11.11.3 Beijing Zizhu Pharmaceutical Co., Ltd Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Beijing Zizhu Pharmaceutical Co., Ltd Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Beijing Zizhu Pharmaceutical Co., Ltd Recent Developments
11.12 Shanghai Pharmaceutical Group
11.12.1 Shanghai Pharmaceutical Group Corporation Information
11.12.2 Shanghai Pharmaceutical Group Overview
11.12.3 Shanghai Pharmaceutical Group Drugs for Enuresis Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Shanghai Pharmaceutical Group Drugs for Enuresis Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shanghai Pharmaceutical Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drugs for Enuresis Industry Chain Analysis
12.2 Drugs for Enuresis Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drugs for Enuresis Production Mode & Process
12.4 Drugs for Enuresis Sales and Marketing
12.4.1 Drugs for Enuresis Sales Channels
12.4.2 Drugs for Enuresis Distributors
12.5 Drugs for Enuresis Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drugs for Enuresis Industry Trends
13.2 Drugs for Enuresis Market Drivers
13.3 Drugs for Enuresis Market Challenges
13.4 Drugs for Enuresis Market Restraints
14 Key Findings in The Global Drugs for Enuresis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer